PamelaP.(Pierce)PalmerMDPhD
Anesthesiology • San Francisco, CAPain Medicine, Pediatric Pain Medicine
Chief Medical Officer and Co-Founder, AcelRx Pharmaceuticals
Dr. Palmer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2255 Post St
San Francisco, CA 94115Phone+1 415-885-7246Fax+1 415-885-7575
Education & Training
University of California (San Francisco)Fellowship, Pain Medicine, 1996 - 1997
Santa Clara Valley Medical CenterInternship, Transitional Year, 1992 - 1993
Stanford University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026- American Board of Anesthesiology Anesthesiology
Publications & Presentations
PubMed
- 4 citationsPatient and Healthcare Professional Satisfaction Ratings and Safety Profile of Sufentanil Sublingual Tablets for Treatment of Acute Pain: A Pooled Demographic Analysis.David A. Leiman, Maurice Jove, Gail Rosen Spahn, Pamela Pierce Palmer
Journal of Pain Research. 2021-03-25 - 8 citationsPooled Dosing and Efficacy Analysis of the Sufentanil Sublingual Tablet 30 mcg Across Demographic Subgroups for the Management of Moderate-to-Severe Acute Pain.Jacob L Hutchins, David Leiman, Zubaid Rafique, Karen P. DiDonato, Pamela P. Palmer
Journal of Perianesthesia Nursing. 2020-02-01 - 16 citationsPooled Phase III safety analysis of sufentanil sublingual tablets for short-term treatment of moderate-to-severe acute pain.James R. Miner, Timothy I. Melson, David Leiman, Harold S. Minkowitz, Yu-Kun Chiang
Pain Management. 2019-01-07
Press Mentions
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical ProcedureApril 8th, 2021- AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery RegimenJanuary 19th, 2021
- AcelRx Pharmaceuticals : Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative SettingAugust 24th, 2020
- Join now to see all
Grant Support
- Transcription Regulation &Interaction Of ORL1 And GAIPNational Institute Of Neurological Disorders And Stroke2004–2007
- Nociceptin &Orl1 Receptor In Synovial Inflammation/PainNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2003
- Subcutaneous Infusion Of Sufentanil Citrate For PainNational Center For Research Resources2000–2002
- 5-HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1997–2001
- 5HT Receptors--Peripheral Pain And InflammationNational Institute Of Neurological Disorders And Stroke1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
